Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
Sign Up to like & getrecommendations! Published in 2017 at "CNS oncology"
DOI: 10.2217/cns-2016-0049
Abstract: BACKGROUND This post hoc analysis of the EF-14 trial (NCT00916409) of tumor-treating fields (TTFields) plus temozolomide versus temozolomide alone in newly diagnosed glioblastoma compared the efficacy of TTFields plus chemotherapy (physician's choice) versus chemotherapy alone… read more here.
Keywords: chemotherapy; plus chemotherapy; ttfields plus; recurrence ... See more keywords